Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat…
The Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat severe COVID-19 patients in the United Kingdom.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthMedicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat…
Sign in or subscribeBrowse free archive reportsThe Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat severe COVID-19 patients in the United Kingdom.